Nucleome
Nucleome Therapeutics is seeking a Principal Scientist with expertise in autoimmunity and translational medicine to lead experimental research linking preclinical findings to clinical relevance. The role involves designing cellular assays, interpreting complex data, and collaborating across multidisciplinary teams to advance early-stage drug discovery programs for inflammatory diseases.
Headquarters
Oxford, England, United Kingdom
Company Size
11-50 employees
Founded
2019
Nucleome is a biotech company focused on unlocking the non‑coding human genome to discover mechanisms and therapeutic targets for inflammatory diseases. Using a platform that combines large‑scale genomics, epigenomics, single‑cell profiling and functional perturbations, they map regulatory elements and link non‑coding variation to disease biology. The company translates those insights into target prioritization and partnerships with drug developers to advance new precision therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Nucleome.
13% below the average for this role
Scientist/Senior Scientist
Flagship Pioneering, Inc.
Principal Scientist, T Cell Immunology (Autoimmunity and Infectious Disease)
Moderna
Monte Rosa Therapeutics Research Associate
Monte Rosa Therapeutics, Inc
POSTDOCTORAL ASSOCIATE
Hospital for Special Surgery
Principal Scientist - Cell Therapy Translational Research
Bristol Myers Squibb
Associate Scientist, Immunology
Flagship Pioneering, Inc.